Common Stock, Shares, Issued of ABVC BIOPHARMA, INC. from Q3 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
ABVC BIOPHARMA, INC. quarterly Common Stock, Shares, Issued history and change rate from Q3 2010 to Q3 2025.
  • ABVC BIOPHARMA, INC. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 24.2M shares, a 90.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 24.2M +11.5M +90.3% 30 Sep 2025 10-Q 03 Nov 2025
Q2 2025 19.5M +7.48M +62.1% 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 15.4M +4.68M +43.7% 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 13.9M +5.93M +74.7% 31 Dec 2024 10-Q 03 Nov 2025
Q3 2024 12.7M +7.89M +164% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 12.1M +8.74M +264% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 10.7M -22.4M -67.7% 31 Mar 2024 10-Q 17 May 2024
Q4 2023 7.94M +4.65M +142% 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 4.82M -27.8M -85.2% 30 Sep 2023 10-Q 15 Nov 2023
Q2 2023 3.31M -29M -89.8% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 33.1M +2.77M +9.15% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 3.29M -21.1M -86.5% 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 32.6M +4.7M +16.8% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 32.3M +7.84M +32% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 30.3M +5.89M +24.1% 31 Mar 2022 10-Q 16 May 2022
Q4 2021 24.4M 0 0% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 27.9M +7.54M +37% 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 24.5M +4.98M +25.6% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 24.4M +4.93M +25.3% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 24.4M +23.8M +3686% 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 20.4M +916K +4.7% 30 Sep 2020 10-Q 17 Nov 2020
Q2 2020 19.5M +1.37M +7.54% 30 Jun 2020 10-Q 14 Aug 2020
Q1 2020 19.5M +1.79M +10.1% 31 Mar 2020 10-Q 29 Jun 2020
Q4 2019 645K -11.2M -94.6% 31 Dec 2019 10-Q 14 Nov 2022
Q3 2019 19.5M -194M -90.9% 30 Sep 2019 10-Q 18 Nov 2019
Q2 2019 18.1M -196M -91.5% 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 17.7M -196M -91.7% 31 Mar 2019 10-Q 28 May 2019
Q4 2018 11.9M -202M -94.4% 31 Dec 2018 10-K 15 May 2020
Q3 2018 214M +180K +0.08% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 214M +180K +0.08% 30 Jun 2018 10-Q 20 Aug 2018
Q1 2018 214M +180K +0.08% 31 Mar 2018 10-Q 15 May 2018
Q4 2017 214M +2.93M +1.39% 31 Dec 2017 10-K 15 May 2020
Q3 2017 214M +2.93M +1.39% 30 Sep 2017 10-KT 13 Apr 2018
Q2 2017 214M +4.39M +2.1% 30 Jun 2017 10-Q 19 Mar 2018
Q1 2017 214M +4.99M +2.39% 31 Mar 2017 10-Q/A 19 Mar 2018
Q4 2016 211M +145M +222% 31 Dec 2016 10-Q/A 19 Mar 2018
Q3 2016 211M +44.5M +26.8% 30 Sep 2016 10-Q 19 Mar 2018
Q2 2016 209M +155M +283% 30 Jun 2016 10-Q 22 Feb 2017
Q1 2016 209M +154M +282% 31 Mar 2016 10-Q 17 May 2016
Q4 2015 65.4M +10.8M +19.9% 31 Dec 2015 10-Q 23 Feb 2016
Q3 2015 166M +166M 30 Sep 2015 10-K/A 22 Sep 2017
Q2 2015 54.6M 0 0% 30 Jun 2015 10-Q 19 Aug 2015
Q1 2015 54.6M 0 0% 31 Mar 2015 10-Q 05 Jun 2015
Q4 2014 54.6M 0 0% 31 Dec 2014 10-Q 17 Apr 2015
Q3 2014 11.1K* -54.6M 30 Sep 2014 10-Q 23 Feb 2016
Q2 2014 54.6M 0 0% 30 Jun 2014 10-Q 17 Apr 2015
Q1 2014 54.6M 0 0% 31 Mar 2014 10-Q 17 Apr 2015
Q4 2013 54.6M 0 0% 31 Dec 2013 10-Q 17 Apr 2015
Q3 2013 54.6M +40.4M +286% 30 Sep 2013 10-Q 17 Apr 2015
Q2 2013 54.6M +53.2K +0.1% 30 Jun 2013 10-Q 16 Apr 2015
Q1 2013 54.6M +38.3M +234% 31 Mar 2013 10-Q 16 Apr 2015
Q4 2012 54.6M +38.3M +234% 31 Dec 2012 10-Q 16 Apr 2015
Q3 2012 14.2M 0 0% 30 Sep 2012 10-K 16 Apr 2015
Q2 2012 54.5M +43.9M +412% 30 Jun 2012 10-Q/A 20 Aug 2012
Q1 2012 16.3M 31 Mar 2012 10-Q 15 May 2012
Q4 2011 16.3M 31 Dec 2011 10-Q 21 Feb 2012
Q3 2011 14.2M -18.8M -57% 30 Sep 2011 10-K 15 Apr 2015
Q2 2011 10.7M 30 Jun 2011 10-Q/A 08 Sep 2011
Q3 2010 32.9M 30 Sep 2010 10-K/A 28 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.